Ou et al. (2024) have shown that the UBA2 expression is associated with tumor progression, immune modulation, and radiosensitivity in glioma, and suggested it as a prognostic biomarker and a potential treatment target [42]. This evidence concerns the gene UBA2 and central nervous system cancer.